Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is a medical technology firm in the healthcare sector dedicated to advancing patient care through the development, production, and commercialization of sophisticated tools. Headquartered in Sunnyvale, US, the company was established in 1995. With 17,021 employees, it provides innovations that…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
1D
-0.3%
1W
+0.6%
1M
+11.6%
6M
-9.1%
YTD
-24.7%
1Y
-1.8%
2Y
-10.5%
5Y
+28.7%
10Y
+437.2%
Next earnings date
20/10/2026 (in 3 days)
Volatility around earnings
~49% stronger price swings than usual
PRICE TARGET LOW
US$357.44
CONSENSUS
US$480.78
MEDIAN
US$486.00
PRICE TARGET HIGH
US$600.00
0
STRONG BUY
40
BUY
12
HOLD
5
SELL
0
STRONG SELL
57
TOTAL · Buy
As of: 12/10/2026
P/E
48.21
P/B
8.33
EV/EBITDA
32.61
RETURN ON EQUITY
4.5%
NET MARGIN
28.3%
DEBT/EQUITY
0
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
99.4%
FLOAT SHARES
351,179,566
AVG. DAILY VOLUME (30D)
2,258,669
WADORS PATRICIA L
WADORS PATRICIA L
LOEB GARY
LOEB GARY
Widman Fredrik
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -0.3%
Forums (Reddit)
See the full forum history with Pro.
Intuitive Surgical, Inc. is a company in the Healthcare sector, Medical - Instruments & Supplies industry, headquartered in United States.
The CEO is David J. Rosa, the company employs around 17,021 people.
The IPO was on 16/06/2000; the stock trades on NASDAQ under the ticker ISRG.
57 analysts rate the stock, the consensus is Buy (as of 12/10/2026).
The average price target is US$480.78, ranging from US$357.44 to US$600.00, with a median of US$486.00.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 20/10/2026.
Around past earnings, price swings were roughly 49% stronger than usual.
No, Intuitive Surgical currently does not pay a dividend.
Comparable stocks include Becton, Dickinson and Company, ResMed, West Pharmaceutical Services, Solventum, Baxter International, Cooper Companies, Avantor and Repligen.
Clicking "Analyze stock" lets five strategies assess Intuitive Surgical against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.